Amylyx Pharmaceuticals (AMLX) Raw Materials (2022)

Amylyx Pharmaceuticals has reported Raw Materials for 1 years, with the latest figure at $7.2 million in Q4 2022.

• On a quarterly basis, Raw Materials changed N/A year-over-year to $7.2 million in Q4 2022; TTM through Dec 2022 was $7.2 million, a N/A change from a year earlier, with the FY2022 full-year figure at $7.2 million, changed N/A from the prior year.
• Raw Materials was $7.2 million for Q4 2022 at Amylyx Pharmaceuticals, up from $408000.0 in the prior quarter.
• The five-year high for Raw Materials was $7.2 million in Q4 2022, with the low at $408000.0 in Q3 2022.